Intervention

Risperidone 4mg/day

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

4 shown

Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With SchizophreniaNCT07523256 · 2025-11-01

Effectiveness of Ashwagandha in Schizophrenia Patients on RisperidoneNCT07575516 · 2025-10-01

Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia PatientsNCT07541157 · 2025-09-01

Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of SchizophreniaNCT00768612 · 2008-11-01

Common conditions

Schizophrenia2 Schizophrenia Patients2 Neuroinflammation1 Psychotic Disorders1

Leading sponsors

Hasanuddin University2 Rinvil Renaldi1 Wyeth is now a wholly owned subsidiary of Pfizer1

Trial status mix

COMPLETED3

WITHDRAWN1

Phase mix

NA2

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.